Celltrion
068270.KS
#734
Rank
โ‚น2.339 T
Marketcap
โ‚น10,873
Share price
0.45%
Change (1 day)
-5.01%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น258.06. In 2022 the company made an earnings per share (EPS) of โ‚น251.22 a decrease over its 2021 EPS that were of โ‚น298.51.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-2.37%
2022โ‚น251.22-15.84%
2021โ‚น298.5112.77%
2020โ‚น264.7070.79%
2019โ‚น154.9915.63%
2018โ‚น134.04-33.13%
2017โ‚น200.46141.17%
2016โ‚น83.128.28%
2015โ‚น76.7611.28%
2014โ‚น68.9816.37%
2013โ‚น59.28-67.42%
2012โ‚น181.9784.22%
2011โ‚น98.7862.13%
2010โ‚น60.9380.61%
2009โ‚น33.73-559.63%
2008-โ‚น7.34-123.16%
2007โ‚น31.69